Equity Instruments (Details 2) - USD ($) |
3 Months Ended | |
---|---|---|
Sep. 30, 2016 |
Sep. 30, 2015 |
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Unrecognized expense at September 30, 2016 | $ 1,906,000 | |
Weighted average remaining years to vest (in years) | 2 years 5 months 23 days | |
Stock Options [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Allocated Share-based Compensation Expense | $ 1,044,000 | $ 68,000 |
Research and Development Expense [Member] | Stock Options [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Allocated Share-based Compensation Expense | 0 | 5,000 |
Selling, General and Administrative Expenses [Member] | Stock Options [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Allocated Share-based Compensation Expense | $ 1,044,000 | $ 63,000 |